Skip to content
Dose Brief
Menu

Briefs · 40 desks

Every desk on the board, scored

Each GLP-1 telehealth desk we track, graded on the Brief Score — price stability, supply reliability, transparency and access.

Showing 140 of 495. Most recent verification in the roster: .

Grade A

The strongest on price stability and supply.

Grade B

Solid desks with a trade-off worth reading first.

Brief Scores are our editorial judgment per the methodology; facts reflect each desk's public disclosures at last check. A commission never changes a score, and it never softens what we write about a desk — see our disclosure. Not medical advice.

The desk's No. 1 · 94/100

CoreAge Rx

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Semaglutide
$149/mo
Tirzepatide
$349/mo
Visit CoreAge Rx
Full brief →Ad disclosure — we may earn a commission.

Shopping on price?

See every desk with its price direction and the note behind it.

Open the board →